Live Breaking News & Updates on Enhancing Anti Viral

Stay updated with breaking news from Enhancing anti viral. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

XORTX Therapeutics Inc.: XORTX Files New Provisional Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection


XORTX Therapeutics Inc.: XORTX Files New Provisional Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection
CALGARY, AB / ACCESSWIRE / March 8, 2021
/ XORTX Therapeutics Inc.
XORTX or the
Company ) (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, with late-stage clinical programs, is pleased to announce the filing of a new provisional patent application entitled Compositions and Methods for Enhancing Anti-Viral Therapies . This provisional patent was filed with the US Patent Office on Friday, March 5, 2021.
In addition, studies of Coronavirus infections show that SARS and MERS and specifically COVID-19 can be frequently accompanied by pneumonia, acute kidney injury, proteinuria and hematuria ....

Cheng Liu , Vivekanand Jha , Allen Davidoff , Shang Jyh Hwang , Jiang Hua Chen , Chih Wei Yang , Bruce Rowlands , Saraladevi Naicker , Kidney International , Therapeutics Inc , Us Patent Office On , Enhancing Anti Viral , Bi Cheng Liu , Novel Coronavirus , Kidney International March , Kidney Impairment , Patients With , Coronavirus Infected Pneumonia , Kidney Dysfunctions , Nature Reviews Immunology , Autosomal Dominant Polycystic Kidney Disease , செங் லியூ , விவேகானந்த் ஜா , ஆலன் டேவிட்ஆஃப் , ஜியாங் ஹுவா சென் , சிஹ் வெய் யாங் ,